Location History:
- Waterford, CT (US) (2010 - 2019)
- East Lyme, CT (US) (2022 - 2024)
Company Filing History:
Years Active: 2010-2024
Title: Jun Xiao: Innovator in Pharmaceutical Compounds
Introduction
Jun Xiao is a prominent inventor based in Waterford, CT (US), known for his significant contributions to the field of pharmaceuticals. He holds a total of 7 patents, showcasing his innovative approach to developing new treatments for various medical conditions.
Latest Patents
Among his latest patents, Jun Xiao has developed toll-like receptor agonists. These inventions relate to imidazo-pyridinyl compounds, or pharmaceutically acceptable salts thereof. His work includes pharmaceutical compositions comprising such compounds and salts, as well as methods for using these compounds, salts, and compositions for treating abnormal cell growth, including cancer, in a subject.
Career Highlights
Throughout his career, Jun Xiao has made notable advancements in pharmaceutical research. His expertise has led to the development of groundbreaking treatments that address critical health issues. His work is recognized for its potential impact on cancer therapies.
Collaborations
Jun Xiao has collaborated with esteemed professionals in the field, including Michael Luzzio and Samit Kumar Bhattacharya. These partnerships have contributed to the success of his innovative projects.
Conclusion
Jun Xiao's contributions to pharmaceutical innovations highlight his dedication to improving healthcare through research and development. His patents reflect a commitment to finding effective treatments for serious medical conditions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.